Cercare Medical Inc

Cercare Medical A/S is a Denmark-based medical imaging software company specializing in advanced perfusion and metabolic imaging solutions for neurological and oncological applications. Founded in 2001 by Professor Kim Beuschau Mouridsen and PhD Mikkel Bo Hansen, the company develops automated, on-premise perfusion imaging software compatible with any MRI and CT scanner platform. Cercare Perfusion software generates unique biomarker maps including Capillary Transit-Time Heterogeneity (CTH), Oxygen Extraction Fraction (OEF), Cerebral Metabolic Rate of Oxygen (CMRO₂), relative Cerebral Blood Volume (rCBV), relative Cerebral Blood Flow (rCBF), and Mean Transit Time (MTT). Clinical applications include acute ischemic stroke assessment, brain tumor characterization and grading, neurodegenerative disease monitoring, and oncology applications. The Cercare Medical Neurosuite (CMN) integrates AI-enabled modules for automated detection and segmentation of hypoperfusion and ischemic core regions. The company's CBCT (cone-beam CT) perfusion capability provides real-time analysis in angiography suites, enabling direct-to-angio workflows and post-intervention assessment. Cercare operates globally with authorized distribution partners including Siemens, Terabox, AIDOC, VIZ, Sectra, and Microsoft, serving hospitals in multiple countries with over 1 million annual diagnoses supported. The software is vendor-agnostic, operates on-premise with no cloud dependency, and is designed for stroke, oncology, Alzheimer's disease, dementia, and neoplasia applications.